Radiolabeled inorganic nanoparticles for positron emission tomography imaging of cancer: an overview
- 1 March 2017
- journal article
- review article
- Published by Edizioni Minerva Medica in The Quarterly Journal of Nuclear Medicine and Molecular Imaging
- Vol. 61 (2), 181-204
- https://doi.org/10.23736/S1824-4785.17.02969-7
Abstract
Over the last few years, a plethora of radiolabeled inorganic nanoparticles have been developed and evaluated for their potential use as probes in positron emission tomography (PET) imaging of a wide variety of cancers. Inorganic nanoparticles represent an emerging paradigm in molecular imaging probe design, allowing the incorporation of various imaging modalities, targeting ligands, and therapeutic payloads into a single vector. A major challenge in this endeavor is to develop disease-specific nanoparticles with facile and robust radiolabeling strategies. Also, the radiolabeled nanoparticles should demonstrate adequate in vitro and in vivo stability, enhanced sensitivity for detection of disease at an early stage, optimized in vivo pharmacokinetics for reduced non-specific organ uptake, and improved targeting for achieving high efficacy. Owing to these challenges and other technological and regulatory issues, only a single radiolabeled nanoparticle formulation, namely "C-dots" (Cornell dots), has found its way into clinical trials thus far. This review describes the available options for radiolabeling of nanoparticles and summarizes the recent developments in PET imaging of cancer in preclinical and clinical settings using radiolabeled nanoparticles as probes. The key considerations toward clinical translation of these novel PET imaging probes are discussed, which will be beneficial for advancement of the field.Keywords
This publication has 100 references indexed in Scilit:
- cRGD-functionalized, DOX-conjugated, and 64Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imagingBiomaterials, 2011
- Synthesis of 64CuII–Bis(dithiocarbamatebisphosphonate) and Its Conjugation with Superparamagnetic Iron Oxide Nanoparticles: In Vivo Evaluation as Dual‐Modality PET–MRI AgentAngewandte Chemie, 2011
- PET Imaging and Biodistribution of Silicon Quantum Dots in MiceACS Medicinal Chemistry Letters, 2011
- A Chelator-Free Multifunctional [64Cu]CuS Nanoparticle Platform for Simultaneous Micro-PET/CT Imaging and Photothermal Ablation TherapyJournal of the American Chemical Society, 2010
- PET/NIRF/MRI triple functional iron oxide nanoparticlesBiomaterials, 2010
- Hybrid PET-optical imaging using targeted probesProceedings of the National Academy of Sciences of the United States of America, 2010
- In Vivo Evaluation of 64Cu-Labeled Magnetic Nanoparticles as a Dual-Modality PET/MR Imaging AgentBioconjugate Chemistry, 2010
- 18F Labeled Nanoparticles for in Vivo PET-CT ImagingBioconjugate Chemistry, 2009
- Particle Size, Surface Coating, and PEGylation Influence the Biodistribution of Quantum Dots in Living MiceSmall, 2009
- Synthesis of 64Cu-Labeled Magnetic Nanoparticles for Multimodal ImagingBioconjugate Chemistry, 2008